These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 38587028)

  • 1. Metastasis-directed therapy in testicular cancer.
    Pandit K; Yuen K; Puri D; Yodkhunnatham N; Millard F; Bagrodia A
    Curr Opin Urol; 2024 Jul; 34(4):281-285. PubMed ID: 38587028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Extragonadal retroperitoneal germ cell tumors without apparent testicular involvement. A search for the source.
    Saltzman B; Pitts WR; Vaughan ED
    Urology; 1986 Jun; 27(6):504-7. PubMed ID: 3012846
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimal management of retroperitoneal metastatic nonseminomatous testicular cancer: toward a better selection between scalpel and needle.
    de Wit R
    J Clin Oncol; 2007 Dec; 25(35):5550-2. PubMed ID: 18065727
    [No Abstract]   [Full Text] [Related]  

  • 4. Treatment of Relapse of Clinical Stage I Nonseminomatous Germ Cell Tumors on Surveillance.
    Hamilton RJ; Nayan M; Anson-Cartwright L; Atenafu EG; Bedard PL; Hansen A; Chung P; Warde P; Sweet J; O'Malley M; Sturgeon J; Jewett MAS
    J Clin Oncol; 2019 Aug; 37(22):1919-1926. PubMed ID: 30802156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Extragonadal germ cell tumor with the "burned-out" phenomenon presented a multiple retroperitoneal masses: a case report.
    Budak S; Celik O; Turk H; Suelozgen T; Ilbey YO
    Asian J Androl; 2015; 17(1):163-4. PubMed ID: 25219912
    [No Abstract]   [Full Text] [Related]  

  • 6. Management of residual masses in testicular germ cell tumors.
    Heidenreich A; Paffenholz P; Nestler T; Pfister D
    Expert Rev Anticancer Ther; 2019 Apr; 19(4):291-300. PubMed ID: 30793990
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Germinal testicular carcinoma. Clinical aspects, differential diagnosis, indications and surgical treatment of retroperitoneal metastases].
    Sigel A; Schrott KM; Herrlinger A
    MMW Munch Med Wochenschr; 1984 Jan; 126(2):19-24. PubMed ID: 6321975
    [No Abstract]   [Full Text] [Related]  

  • 8. [Management of metastatic testicular germ cell tumors].
    Lavaud P; Baciarello G; Fizazi K
    Bull Cancer; 2019 Oct; 106(10):896-902. PubMed ID: 31466695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of retroperitoneal lymph node metastases in patients with non-seminomatous testicular cancer in clinical stage I.
    Fosså SD; Ous S; Stenwig AE; Lien HH; Aass N; Kaalhus O
    Eur Urol; 1990; 17(2):107-12. PubMed ID: 2155789
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Redefining the refined retroperitoneal lymph node dissection in testis cancer: a SWOT analysis of nonrandomized data.
    Garnick MB
    J Clin Oncol; 2007 Oct; 25(28):4337-8. PubMed ID: 17906195
    [No Abstract]   [Full Text] [Related]  

  • 11. Testicular germ cell tumor seven years after a retroperitoneal germ cell tumor.
    González Quintela A; López Bonet E; Román J; Aramburo P
    Eur Urol; 1991; 19(4):336-8. PubMed ID: 1655464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Postchemotherapy residual tumour resection in complex metastatic sites of advanced testicular germ cell tumours].
    Paffenholz P; Pfister D; Heidenreich A
    Urologe A; 2016 May; 55(5):632-40. PubMed ID: 26820659
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Treatment of patients with retroperitoneal metastases of nonseminoma tumors of the testis].
    Matveev BP; Figurin KM
    Vopr Onkol; 1988; 34(12):1493-7. PubMed ID: 2464238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Follow-up of testicular germ cell cancer patients: interdisciplinary evidence-based recommendations].
    Hartmann M; Krege S; Souchon R; De Santis M; Gillessen S; Cathomas R;
    Urologe A; 2011 Jul; 50(7):830-5. PubMed ID: 21503662
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nonrandomized comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer.
    Stephenson AJ; Bosl GJ; Motzer RJ; Bajorin DF; Stasi JP; Sheinfeld J
    J Clin Oncol; 2007 Dec; 25(35):5597-602. PubMed ID: 18065732
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence of metastatic nonseminomatous germ cell tumor outside the boundaries of a modified postchemotherapy retroperitoneal lymph node dissection.
    Carver BS; Shayegan B; Eggener S; Stasi J; Motzer RJ; Bosl GJ; Sheinfeld J
    J Clin Oncol; 2007 Oct; 25(28):4365-9. PubMed ID: 17906201
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Testicular germ cell tumors: biology and clinical update.
    Mannuel HD; Mitikiri N; Khan M; Hussain A
    Curr Opin Oncol; 2012 May; 24(3):266-71. PubMed ID: 22343384
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Enlarging residual mass after treatment of a nonseminomatous germ cell tumor: growing teratoma syndrome or cancer recurrence?
    Aide N; Comoz F; Sevin E
    J Clin Oncol; 2007 Oct; 25(28):4494-6. PubMed ID: 17906212
    [No Abstract]   [Full Text] [Related]  

  • 19. [Extratesticular germinal cell tumors].
    Base J
    Rozhl Chir; 1989 Nov; 68(11):776-80. PubMed ID: 2561025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Urologic treatment of testicular germ cell cancer].
    Fernández Gómez JM; Escaf Barmadah S; Guate Ortiz JL; Martín Huescar A; Fresno Forcelledo F; García Rodríguez J; Rodríguez Faba O; Jalón Monzón A; Rodríguez Martínez JJ
    Arch Esp Urol; 2002 Oct; 55(8):927-36. PubMed ID: 12455283
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.